ABUS vs AAPL: Which Stock is Better?
Side-by-side comparison of Arbutus Biopharma Corp and Apple Inc in 2026
ABUS
Arbutus Biopharma Corp
$4.53
AAPL
Apple Inc
$256.90
Key Metrics Comparison
| Metric | ABUS | AAPL | Winner |
|---|---|---|---|
| Market Cap | $871.23M | N/A | ABUS |
| P/E Ratio | N/A | 32.88 | AAPL |
| EPS (TTM) | $N/A | $7.83 | AAPL |
| Revenue Growth | -0.6% | 0.2% | AAPL |
| Gross Margin | -98.9% | 47.3% | AAPL |
Analyze ABUS
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ABUS or AAPL a better investment?
Comparing ABUS and AAPL: Arbutus Biopharma Corp has a market cap of $871.23M while Apple Inc has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ABUS and AAPL?
ABUS (Arbutus Biopharma Corp) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ABUS or AAPL?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ABUS or AAPL?
AAPL has higher revenue growth at 0.2% vs -0.6% for ABUS.
Which company is more profitable: ABUS or AAPL?
Apple Inc (AAPL) has higher gross margins at 47.3% compared to -98.9% for ABUS.
Which is the larger company: ABUS or AAPL?
Arbutus Biopharma Corp (ABUS) is larger with a market cap of $871.23M compared to N/A for AAPL.
Should I buy ABUS or AAPL in 2026?
Both ABUS and AAPL have investment merit. ABUS trades at $4.53 while AAPL trades at $256.90. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ABUS and AAPL stock?
Key differences: Market Cap ($871.23M vs N/A), P/E Ratio (N/A vs 32.9x), Revenue Growth (-0.6% vs 0.2%), Gross Margin (-98.9% vs 47.3%).